Search

MSK’s new Robert and Kate Niehaus Center for Inherited Cancer Genomics is using the latest in gene sequencing technologies to discover the inherited causes of cancer.

On World Cancer Day, MSK Launches Public-Service Announcement ‘Late,’ Emphasizing the Urgency and Power of Routine Cancer Screenings

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.

Microsatellite instability (MSI) and DNA mismatch repair (MMR) deficiencies can predict Lynch syndrome (LS) across tumor types, according to researchers from Memorial Sloan Kettering Cancer Center (MSK), who presented this retrospective data analysis in a press conference at the annual meeting of the American Society of Clinical Oncology. This finding suggests that LS is linked to more types of cancer than previously thought, prompting a call for germline testing for LS in all individuals with MSI-high (MSI-H)/mismatch repair deficient (MMR-D) tumors.

Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.

The new Fiona and Stanley Druckenmiller Center for Lung Cancer Research brings together MSK physicians and scientists in an intensive, multidisciplinary effort against the number-one cause of death from cancer in the nation.

Surgical resection of symptomatic, benign intradural extramedullary (IDEM) spine tumors provides rapid, significant, and durable improvements in patient-reported outcomes.